<DOC>
	<DOC>NCT02829749</DOC>
	<brief_summary>The main objective is to assess the effectiveness and safety of the NeoChord DS1000 repair technique as compared with conventional open-heart on-pump mitral valve surgery in patients with severe primary mitral regurgitation.</brief_summary>
	<brief_title>Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Severe primary mitral regurgitation (grade 3+ or 4+) Class I indication for MV Surgery according to ESC/EACTS and AHA/ACC guidelines: 1. Symptomatic patients and/or 2. LV (Left Ventricular) dysfunction : LVESD ≥45 mm and/or 30≤ LVEF ≤60% Leaflet prolapse of P2 and/or A2 Predicted coaptation length &gt; 4 mm Candidates for surgical mitral valve repair according to heart team Patient able to sign an informed consent form Patient benefiting from a social insurance system or a similar system Asymptomatic patients with preserved LV function Complex mechanism of MR (leaflet perforation, severe calcifications, commissural extension, etc) Secondary MR Predicted postrepair coaptation length less than 4 mm Atrial fibrillation Inflammatory or infective valve disease Severe LV dilation (DTD &gt; 65 mm) Significant mitral annulus dilatation (D &gt; 45 mm) Surgical indication of tricuspid annulus Contraindication to TEE (transesophageal echocardiographic ) or inadequate image quality Need for any other concomitant cardiac procedure Concurrent medical condition with a life expectancy of less than 24 months Patient unable to understand the purpose of the trial Patient &lt; 18 years old Participation to another trial that would interfere with this trial Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Heart Valve Diseases</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Heart diseases</keyword>
	<keyword>Mitral valve insufficiency</keyword>
</DOC>